The Harris and Harris quest for global domination (at least of the nanotech world) continues with a follow-on public offering of 3,000,000 shares of its common stock expected to net them around $31.7 million. With nanotech investments often taking far longer than expected to exit from, its good to see H&H taking the long view, with plenty in reserve for a rainy day while taking advantage of market exuberance.
Its not long since various pundits were calling H&H overvalued at $4-6 and slapping on sell ratings.
Currently at $11.25, H&H mangement look like the cats that got the cream.